AJP - Renal Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 290: F1024-F1033, 2006. First published December 27, 2005; doi:10.1152/ajprenal.00221.2005
0363-6127/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/F1024    most recent
00221.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, X. C.
Right arrow Articles by Zhuo, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, X. C.
Right arrow Articles by Zhuo, J. L.

AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats

Xiao C. Li,1 Duncan J. Campbell,2 Mitsuru Ohishi,3 Shao Yuan,1 and Jia L. Zhuo1

1Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, Michigan; 2St. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, Fitzroy, Victoria; and 3Department of Geriatric Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan

Submitted 25 May 2005 ; accepted in final form 14 December 2005

Angiotensin IV (ANG IV), an active ANG II fragment, has been shown to induce systemic and renal cortical effects by binding to ANG IV (AT4) receptors and activating unique signaling transductions unrelated to classical type 1 (AT1) or type 2 (AT2) receptors. We tested whether ANG IV exerts systemic and renal cortical effects on blood pressure, renal microvascular smooth muscle cells (VSMCs), and glomerular mesangial cells (MC) and, if so, whether AT1 receptor-activated signaling is involved. In anesthetized rats, systemic infusion of ANG II, ANG III, or ANG IV (0.01, 0.1, and 1.0 nmol·kg–1·min–1 iv) caused dose-dependent increases in mean arterial pressure (MAP) and decreases in renal cortical blood flow (CBF; P < 0.01). ANG II also induced dose-dependent reductions in renal medullary blood flow (P < 0.01), whereas ANG IV did not. ANG IV-induced pressor and renal cortical vasoconstriction were completely abolished by AT1 receptor blockade with losartan (5 mg/kg iv; P < 0.05). When ANG IV (1 nmol·kg–1·min–1) was infused directly in the renal artery, CBF was reduced by >30%, and the response was also blocked by losartan (P < 0.01). In the renal cortex, unlabeled ANG IV displaced 125I-labeled [Sar1,Ile8]ANG II binding, whereas unlabeled ANG II (10 µM) inhibited 125I-labeled Nle1-ANG IV (AT4) binding in a concentration-dependent manner (P < 0.01). In freshly isolated renal VSMCs, ANG IV (100 nM) increased intracellular Ca2+ concentration, and the effect was blocked by losartan and U-73122, a selective inhibitor of phospholipase C/inositol trisphosphate/Ca2+ signaling (1 µM). In cultured rat MCs, ANG IV (10 nM) induced mitogen-activated protein kinase extracellular/signal-regulated kinase 1/2 phosphorylation via AT1 receptor- and phospholipase C-activated signaling. These results suggest that, at nanomolar concentrations, ANG IV can increase MAP and induce renal cortical effects by interacting with AT1 receptor-activated signaling.

angiotensin II; angiotensin IV; angiotensin type 1 receptor; angiotensin type 4 receptor; renal cortical blood flow; mitogen-activated protein kinases



Address for reprint requests and other correspondence: J. L. Zhuo, Laboratory of Receptor and Signal Transduction, Division of Hypertension and Vascular Research, Henry Ford Hospital, 2799 West Grand Blvd., Detroit, MI 48202 (e-mail: jzhuo1{at}hfhs.org)




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
X. C. Li and J. L. Zhuo
Intracellular ANG II directly induces in vitro transcription of TGF-{beta}1, MCP-1, and NHE-3 mRNAs in isolated rat renal cortical nuclei via activation of nuclear AT1a receptors
Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1034 - C1045.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
X. C. Li and J. L. Zhuo
In vivo regulation of AT1a receptor-mediated intracellular uptake of [125I]Val5-ANG II in the kidneys and adrenals of AT1a receptor-deficient mice
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F293 - F302.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
X. C. Li and J. L. Zhuo
Selective knockdown of AT1 receptors by RNA interference inhibits Val5-ANG II endocytosis and NHE-3 expression in immortalized rabbit proximal tubule cells
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C367 - C378.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.